Evidence map›Paper›PMID 21538024›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2011

The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival.

Anna G Antonacopoulou, Konstantina Floratou, Vasiliki Bravou, Anastasia Kottorou, Fotinos-Ioannis Dimitrakopoulos, Stella Marousi, Michalis Stavropoulos, Angelos K Koutras, Chrisoula D Scopa, Haralabos P Kalofonos

Abstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Combined Inhibition ofInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Survivin at a glance.Journal of cell science · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Survivin: A molecular biomarker in cancer.The Indian journal of medical research · 2015
    Review
  14. Survivin -31 G/C polymorphism might contribute to colorectal cancer (CRC) risk: a meta-analysis.International journal of clinical and experimental medicine · 2015
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Anna G AntonacopoulouMolecular Oncology Laboratory, Medical School, University of Patras, Rion, Greece.
Konstantina Floratou
Vasiliki Bravou
Anastasia Kottorou
Fotinos-Ioannis Dimitrakopoulos
Stella Marousi
Michalis Stavropoulos
Angelos K Koutras
Chrisoula D Scopa
Haralabos P Kalofonos
University of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurvivin is involved in the regulation of cell division and survival, two key processes in cancer. The majority of studies on survivin in colorectal cancer (CRC) have focused on protein expression and less is known about the expression of survivin splicing variants or survivin gene polymorphisms in CRC. In the present study, the mRNA levels of the five known isoforms of survivin as well as survivin protein were assessed in matched normal and neoplastic colorectal tissue. Moreover, the 9386 C/T and -31 G/C polymorphisms were investigated.

methodsQuantitative RT-PCR was used to assess mRNA levels in fresh/frozen tissue samples. Protein levels were immunohistochemically evaluated on formalin-fixed paraffin-embedded tissue sections. Individuals were genotyped using real time PCR.

resultsExpression of all 5 survivin splice variants as well as survivin protein was elevated in colorectal carcinomas compared to normal tissue. Specific splice variant expression differentially correlated with clinicopathological parameters. Furthermore, both snps correlated with splice variant levels or their ratios in colorectal carcinomas while the -31 G/C snp may be related to CRC development and improved overall survival.

conclusionOur results support a role of survivin in colorectal carcinogenesis while the -31 G/C snp may constitute a marker of survival.

Indexed as

Gene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseAgedAged, 80 and overAllelesAlternative SplicingCell DifferentiationColorectal NeoplasmsDisease ProgressionExonsFemaleHumansImmunohistochemistryInhibitor of Apoptosis ProteinsMaleMiddle AgedBIRC5 protein, humanInhibitor of Apoptosis ProteinsSurvivin

Identifiers

PMID21538024
PMCPMC12995091
OpenAlexW2124974083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.